LAVA THERAPEUTICS NV

CUSIP: N51517105 Class: SHS

Redmile Group, LLC's Holding History (CIK: 0001425738)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 2,074,372 Value ($000) $3,236 Avg Close — Range —
Q2 2025
Shares 2,074,372 Value ($000) $2,738 Avg Close — Range —
Q1 2025
Shares 2,074,372 Value ($000) $2,634 Avg Close — Range —
Q4 2024
Shares 2,074,372 Value ($000) $1,973 Avg Close — Range —
Q3 2024
Shares 2,074,372 Value ($000) $3,443 Avg Close — Range —
Q2 2024
Shares 2,074,372 Value ($000) $3,734 Avg Close — Range —
Q1 2024
Shares 2,074,372 Value ($000) $6,908 Avg Close — Range —
Q4 2023
Shares 2,074,372 Value ($000) $3,278 Avg Close — Range —
Q3 2023
Shares 2,074,372 Value ($000) $3,091 Avg Close — Range —
Q2 2023
Shares 2,074,372 Value ($000) $4,211 Avg Close — Range —
Q1 2023
Shares 2,074,372 Value ($000) $3,443 Avg Close — Range —
Q4 2022
Shares 2,816,196 Value ($000) $9,857 Avg Close — Range —
Q3 2022
Shares 2,816,196 Value ($000) $12,870 Avg Close — Range —
Q2 2022
Shares 2,816,196 Value ($000) $8,054 Avg Close — Range —
Q1 2022
Shares 2,816,196 Value ($000) $12,391 Avg Close — Range —
Q4 2021
Shares 2,816,196 Value ($000) $15,489 Avg Close — Range —
Q3 2021
Shares 2,816,196 Value ($000) $16,672 Avg Close — Range —
Q2 2021
Shares 2,816,196 Value ($000) $30,640 Avg Close — Range —
Q1 2021
Shares 2,824,409 Value ($000) $42,903 Avg Close — Range —